MNOV FY 2021 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$71M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M100.0% margin

Operating Income

-$10M-253.0% margin

Net Income

-$10M-251.0% margin

EPS (Diluted)

$-0.21

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$87M

Total Liabilities

$4M

Stockholders' Equity

$84M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$4M	$0	—
Operating Income	-$10M	-$14M	+27.9%
Net Income	-$10M	-$14M	+26.8%